[Current indications for percutaneous transhepatic cholangiography (PTC)]

Percutaneous transhepatic cholangiography (PTC) was once widely used for diagnosing biliary tract obstruction. Its use declined after the rise of endoscopic retrograde cholangiopancreatography (ERCP). However, PTC remains relevant in specific diagnostic scenarios. Prior research has shown that ERCP is often preferred for biliary access and imaging. This paper addresses the current role of PTC in clinical practice. It highlights when PTC is still considered useful despite the availability of ERCP. The study focuses on the diagnostic criteria used to select patients for PTC. It also examines the relationship between biliary dilation and serum enzyme levels. No prior work had resolved the precise role of PTC in modern diagnostic algorithms. This paper provides insights into the conditions where PTC is still indicated.

The study aimed to clarify the current indications for PTC in the context of available alternatives like ERCP. It sought to identify clinical and imaging parameters that justify PTC use. The researchers analyzed 60 cases where PTC was performed for biliary obstruction. They evaluated the relevance of biliary dilation and enzyme levels in decision-making. The goal was to determine when PTC is a resolutive option after ERCP fails. The study also aimed to assess the correlation between imaging findings and biochemical markers. It sought to reinforce the understanding of PTC's role in modern biliary diagnostics. The analysis focused on statistical indicators and clinical outcomes.

The study reviewed 60 cases of obstructive biliary disease where PTC was performed. The selection criteria included biliary dilation and elevated serum enzymes. Echography was used to measure biliary tree diameter. Serum levels of bilirubin, alkaline phosphatase (ALP), and gamma-glutamyl transferase (gamma-GT) were recorded. Statistical analysis evaluated correlations between imaging findings and enzyme levels. The study compared the effectiveness of PTC with ERCP in diagnostic and decompression roles. Clinical outcomes were assessed to determine the utility of PTC. The data were analyzed to support the authors' conclusions about PTC's current role.

The study found a significant correlation between biliary dilation and elevated ALP levels. Bilirubin levels did not show a similar correlation. PTC was used when ERCP was ineffective for diagnosis or decompression. The data supported the view that biliary dilation precedes jaundice. Elevated enzymes can indicate biliary obstruction before dilation is visible. PTC was found to be resolutive in cases where ERCP failed. The study confirmed that PTC remains a second-line diagnostic tool. These findings suggest PTC's role is still relevant in specific clinical scenarios.

The authors propose that PTC remains a second-choice examination compared to ERCP. They suggest that PTC is resolutive when ERCP is ineffective for diagnosis or decompression. The study supports the idea that biliary dilation is a precursor to jaundice. Elevated ALP levels correlate with biliary dilation but not with bilirubin levels. The findings reinforce the clinical utility of PTC in selected cases. The authors do not claim PTC is superior to ERCP but emphasize its role in specific contexts. They propose that PTC should be considered when ERCP is not feasible. These conclusions are based on the data and literature review presented.